Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Candel Therapeutics, Inc. (NASDAQ: CADL) is capturing attention in the biotechnology sector with its ambitious clinical programs and promising potential upside. With a market capitalization of $273.56 million, this United..
Sanara MedTech Inc. (NASDAQ: SMTI) is carving out a niche within the healthcare sector, specifically in the medical instruments and supplies industry. Based in Fort Worth, Texas, this innovative company..
Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, is making waves in the healthcare sector with its promising pipeline of LAG-3 related immunotherapies. As a late-stage biotech company, Immutep is..
Heron Therapeutics, Inc. (NASDAQ: HRTX) is capturing investor attention with its substantial 203.40% potential upside, according to analyst ratings. As a player in the biotechnology sector, Heron Therapeutics focuses on..
Alpha Tau Medical Ltd. (NASDAQ: DRTS), a Jerusalem-based biotechnology firm, is garnering significant attention with its groundbreaking work in oncology therapeutics. Specializing in diffusing alpha-emitters radiation therapy (Alpha DaRT), the..
Cytek Biosciences, Inc. (NASDAQ: CTKB), a pivotal player in the healthcare sector’s medical devices industry, offers a tantalizing 67.15% potential upside according to analyst ratings. With its roots firmly planted..
Entrada Therapeutics, Inc. (NASDAQ: TRDA) is making waves in the biotech sector with its innovative approach to treating neuromuscular diseases. With its market cap standing at $299.83 million, this clinical-stage..
Absci Corporation (NASDAQ: ABSI), a pioneering entity in the biotechnology sector, is drawing considerable attention from investors, primarily due to its robust potential for upside. With a current market cap..
Anbio Biotechnology (NNNN), a promising player in the healthcare sector, specializes in medical instruments and supplies, with a focus on in vitro diagnostics (IVD) products. Based in Frankfurt, Germany, the..
Investors with an appetite for risk-reward scenarios in the biotech sector might want to take a closer look at Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL). With a market capitalization of $378.72..
The Pennant Group, Inc. (NASDAQ: PNTG) has emerged as a noteworthy player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of..
Evolent Health, Inc. (NASDAQ: EVH) stands out in the healthcare sector, particularly within the health information services industry, as an intriguing investment opportunity. With a market capitalization of $995.55 million..
BioLife Solutions, Inc. (BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.13 billion, BioLife Solutions is a..
For investors eyeing opportunities in the biotechnology sector, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) presents an intriguing case. With a current market capitalization of $1.1 billion, this Canadian-based biopharmaceutical company is..
Mesoblast Limited (NASDAQ: MESO), an innovative player in the biotechnology sector, is capturing investor attention with a significant potential upside of 127.85%, according to recent analyst target prices. Headquartered in..
Establishment Labs Holdings Inc (NASDAQ: ESTA), a pioneering medical technology company in the healthcare sector, is making waves with its innovative solutions in the aesthetic and reconstructive plastic surgery industry...
Biohaven Ltd. (NYSE: BHVN) presents a compelling case for investors intrigued by the biotechnology sector, with its substantial potential upside of 222.65% based on current analyst ratings. This upside, coupled..
Investors looking for promising opportunities in the healthcare sector might find LeMaitre Vascular, Inc. (NASDAQ: LMAT) an intriguing option. This Burlington, Massachusetts-based company, a prominent player in the medical instruments..
CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector specializing in medical devices, offers an intriguing investment opportunity for those looking to capitalize on its robust market presence..
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of dermatological treatments. Founded in 2016 and headquartered..
